Chong Kun Dang Gochon Foundation Selects Indian Molecular Diagnostics Company for 18th Gochon Award

Expanding Access to Early Diagnosis
for Over 40 Infectious Diseases Including Tuberculosis, Hepatitis, and HPV

The Chong Kun Dang Gochon Foundation announced on the 30th that it has selected Molbio Diagnostics, an Indian company specializing in molecular diagnostics, as the recipient of the 18th Gochon Award.

Sri Ram Natarajan, CEO of Molbio Diagnostics, winner of the 18th Gochon Award. Chong Kun Dang Pharmaceutical Corp.

This year's Gochon Award focused on the theme of "Introducing New Technologies and Achieving Innovation and Results in the Process of Ending Tuberculosis." Molbio Diagnostics was recognized for its contribution to strengthening the global health diagnostics system through the development of its point-of-care molecular diagnostics platform, Truenat.

Truenat, developed by Molbio Diagnostics, is the first point-of-care (POC) molecular diagnostics platform officially recommended by the World Health Organization (WHO). It can be powered by solar batteries, enabling accurate diagnostics even in settings with limited electricity and laboratory infrastructure. In addition to tuberculosis, it is used to diagnose more than 40 infectious diseases, including COVID-19, hepatitis, and HPV.

This device has been distributed in countries such as India, Nigeria, the Philippines, and Bangladesh through collaborations with international organizations including the WHO, the Foundation for Innovative New Diagnostics (FIND), and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Globally, more than 10,000 units are in use, and over 15 million tuberculosis tests have been conducted, achieving tangible results in the fight against tuberculosis.

Sriram Natarajan, CEO of Molbio Diagnostics, stated, "Receiving the Gochon Award is a great honor and a new source of motivation for our team, which has been dedicated to eradicating tuberculosis. We will continue to accelerate research into new sample types and the development of new technologies to contribute to human health."

Chung Jaejung, Chairman of the Chong Kun Dang Gochon Foundation, commented, "Molbio Diagnostics has created a turning point in the global fight against tuberculosis through its innovative technology. I hope that, going forward, various scientific technologies will be applied to the eradication of tuberculosis and other diseases, providing treatment opportunities to patients in underprivileged environments."

This content was produced with the assistance of AI translation services.